- Home
- BMBL vs PGEN Comparison
BMBL vs PGEN Comparison
Compare BMBL & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMBL
- PGEN
- Stock Information
- Founded
- BMBL 2014
- PGEN 1998
- Country
- BMBL United States
- PGEN United States
- Employees
- BMBL N/A
- PGEN N/A
- Industry
- BMBL Computer Software: Prepackaged Software
- PGEN Biotechnology: Pharmaceutical Preparations
- Sector
- BMBL Technology
- PGEN Health Care
- Exchange
- BMBL Nasdaq
- PGEN Nasdaq
- Market Cap
- BMBL 446.5M
- PGEN 404.4M
- IPO Year
- BMBL 2021
- PGEN N/A
- Fundamental
- Price
- BMBL $5.20
- PGEN $1.45
- Analyst Decision
- BMBL Hold
- PGEN Strong Buy
- Analyst Count
- BMBL 16
- PGEN 3
- Target Price
- BMBL $6.38
- PGEN $6.00
- AVG Volume (30 Days)
- BMBL 2.3M
- PGEN 1.6M
- Earning Date
- BMBL 08-06-2025
- PGEN 08-13-2025
- Dividend Yield
- BMBL N/A
- PGEN N/A
- EPS Growth
- BMBL N/A
- PGEN N/A
- EPS
- BMBL N/A
- PGEN N/A
- Revenue
- BMBL $1,050,969,000.00
- PGEN $4,201,000.00
- Revenue This Year
- BMBL N/A
- PGEN $158.57
- Revenue Next Year
- BMBL N/A
- PGEN $1,086.91
- P/E Ratio
- BMBL N/A
- PGEN N/A
- Revenue Growth
- BMBL N/A
- PGEN N/A
- 52 Week Low
- BMBL $3.55
- PGEN $0.65
- 52 Week High
- BMBL $10.66
- PGEN $2.17
- Technical
- Relative Strength Index (RSI)
- BMBL 47.34
- PGEN 53.70
- Support Level
- BMBL $4.81
- PGEN $1.47
- Resistance Level
- BMBL $5.41
- PGEN $1.59
- Average True Range (ATR)
- BMBL 0.24
- PGEN 0.11
- MACD
- BMBL -0.05
- PGEN 0.01
- Stochastic Oscillator
- BMBL 41.87
- PGEN 63.64
About BMBL Bumble Inc.
Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company Operates in USA and also Internationally such as United Kingdom, Czech Republic, and others with maximum of revenue from Other Countries.
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.